{"nct_id":"NCT06407934","title":"A Study to Evaluate the Treatment Response and Safety of Two Dose Regimens of Subcutaneous Amlitelimab Compared With Treatment Withdrawal in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis","status":"RECRUITING","status_verified_date":"2025-08","start_date":"2024-05-08","start_date_type":"ACTUAL","primary_completion_date":"2026-06-29","primary_completion_date_type":"ESTIMATED","completion_date":"2027-04-05","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["SNY"]}